Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05614284 · ClinicalTrials.gov registry record · NA
Comparative Analysis of Virtuos and Autograft in Lumbar Fusion
A NA study, sponsored by Orthofix.
- Terminated
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT05614284: Clinical Trial NA study, sponsored by Orthofix.
NCT05614284 is a NA study that was terminated before completion, run by Orthofix. The registered enrollment target is 6 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05614284, a NA study, was terminated before completion, sponsored by Orthofix.
- TERMINATED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
Compare the lumbar fusion rates at 12 and 24 months when lumbar arthrodesis is performed using Virtuos or Autograft Bone Graft. Surgical approach is limited to TLIF (MIS or Open) with posterior fixation and supplemental posterolateral fusion as directed by physician, but must comply with FDA approved/cleared indication for use and labeling.
Primary Outcome
Fusion status at Twelve months postoperative
Interventions
- DEVICE Virtuos
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2022-11-14 |
| Est. Completion | 2024-05-16 |
| Phase | NA |
Why NCT05614284 stopped before completion
NCT05614284 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Virtuos is the first listed.
NCT05614284 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05614284 about?
NCT05614284 is a clinical study titled "Comparative Analysis of Virtuos and Autograft in Lumbar Fusion". Compare the lumbar fusion rates at 12 and 24 months when lumbar arthrodesis is performed using Virtuos or Autograft Bone Graft. Surgical approach is limited to TLIF (MIS or Open) with posterior fixation and supplemental posterolateral fusion as directed by physician, but must comply with FDA approve...
What is the current status of trial NCT05614284?
This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2022-11-14. Estimated completion is 2024-05-16.
What interventions are being tested in trial NCT05614284?
The interventions under investigation include: Virtuos (DEVICE).
Who is sponsoring clinical trial NCT05614284?
This trial is sponsored by Orthofix, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05614284's enrollment target sits among peer trials
6 1983rd of 2000 higher than 13 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI